Human umbilical cord matrix-Derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets

DMM Disease Models and Mechanisms

Volumn 8, Issue 12, 2015, Pages 1625-1633

  Zhou, Yunting ^a   Hu, Qi ^a   Chen, Fuyi ^a   Zhang, Juan ^a   Guo, Jincheng ^a   Wang, Hongwu ^a   Gu, Jiang ^a   Ma, Lian ^b   Ho, Guyu ^a  

^a SHANTOU UNIVERSITY   (China)

^b SHENZHEN UNIVERSITY   (China)

Author keywords

Diabetes; Growth factors; IGF1; Stem cells; cells

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PANCREAS ENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CELL TRACKING; CELL VIABILITY; CELLULAR SECRETION; COCULTURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; ENZYME ACTIVATION; GENE SILENCING; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOMODULATION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; ISOLATED PANCREAS ISLET; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEM CELL CULTURE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UMBILICAL CORD MATRIX DERIVED STEM CELL TRANSPLANTATION; WEIGHT REDUCTION; ANIMAL; COMPLICATION; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE SURVIVAL; UMBILICAL CORD;

ANIMALS; CELL SURVIVAL; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; STREPTOZOCIN; TISSUE SURVIVAL; UMBILICAL CORD; WEIGHT LOSS;

EID: 84952776082     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.021857     Document Type: Article

References (37)

1. Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M. and Sayegh, M. H. (2008). Immunomodulation by mesenchymal stem cells: A potential therapeutic strategy for type 1 diabetes. Diabetes 57, 1759-1767.
2. Agudo, J., Ayuso, E., Jimenez, V., Salavert, A., Casellas, A., Tafuro, S., Haurigot, V., Ruberte, J., Segovia, J. C., Bueren, J. et al. (2008). IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia 51, 1862-1872.
3. American Diabetes Association (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care 37 Suppl. 1, S81-S90.
4. Anguela, X. M., Tafuro, S., Roca, C., Callejas, D., Agudo, J., Obach, M., Ribera, A., Ruzo, A., Mann, C. J., Casellas, A. et al. (2013). Nonviral-mediated hepatic expression of IGF-I increases Treg levels and suppresses autoimmune diabetes in mice. Diabetes 62, 551-560.
5. Baraniak, P. R. and McDevitt, T. C. (2010). Stem cell paracrine actions and tissue regeneration. Regen. Med. 5, 121-143.
6. Bassi, E. J., Moraes-Vieira, P. M. M., Moreira-Sa, C. S. R., Almeida, D. C., Vieira, L. M., Cunha, C. S., Hiyane, M. I., Basso, A. S., Pacheco-Silva, A. and Camara, N. O. S. (2012). Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61, 2534-2545.
7. Batsali, A. K., Kastrinaki, M.-C., Papadaki, H. A. and Pontikoglou, C. (2013). Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr. Stem Cell Res. Ther. 8, 144-155.
8. Bensellam, M., Laybutt, D. R. and Jonas, J.-C. (2012). The molecular mechanisms of pancreatic beta-cell glucotoxicity: Recent findings and future research directions. Mol. Cell. Endocrinol. 364, 1-27.
9. Berezin, A. E. (2014). Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives. World J. Diabetes 5, 777-786.
10. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M. and Permutt, M. A. (2001). Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 108, 1631-1638.
11. Bilbao, D., Luciani, L., Johannesson, B., Piszczek, A. and Rosenthal, N. (2014). Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease. EMBO Mol. Med. 6, 1423-1435.
12. Bromberg, J. S., Kaplan, B., Halloran, P. F. and Robertson, R. P. (2007). The islet transplant experiment: Time for a reassessment. Am. J. Transplant. 7, 2217-2218.
13. Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J. and Kim, S. K. (2011). PDGF signalling controls age-dependent proliferation in pancreatic beta-cells. Nature 478, 349-355.
14. Chen, Z., Morris, D. L., Jiang, L., Liu, Y. and Rui, L. (2014). SH2B1 in beta-cells promotes insulin expression and glucose metabolism in mice. Mol. Endocrinol. 28, 696-705.
15. Clemmons, D. R. (2012). Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol. Metab. Clin. North Am. 41, 425-443, vii-viii.
16. Clemmons, D. R. and Maile, L. A. (2003). Minireview: integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 144, 1664-1670.
17. Dai, C., Huh, C.-G., Thorgeirsson, S. S. and Liu, Y. (2005). Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am. J. Pathol. 167, 429-436.
18. Deak, E., Seifried, E. and Henschler, R. (2010). Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications. Int. Rev. Immunol. 29, 514-529.
19. Ezquer, F., Ezquer, M., Contador, D., Ricca, M., Simon, V. and Conget, P. (2012). The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells 30, 1664-1674.
20. Garcia-Ocana, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C. and Stewart, A. F. (2000). Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J. Biol. Chem. 275, 1226-1232.
21. George, M., Ayuso, E., Casellas, A., Costa, C., Devedjian, J. C. and Bosch, F. (2002). Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J. Clin. Invest. 109, 1153-1163.
22. Gruessner, R. W. G. and Gruessner, A. C. (2013). The current state of pancreas transplantation. Nat. Rev. Endocrinol. 9, 555-562.
23. Heit, J. J., Karnik, S. K. and Kim, S. K. (2006). Intrinsic regulators of pancreatic beta-cell proliferation. Annu. Rev. Cell Dev. Biol. 22, 311-338.
24. Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D. A. and Bhatia, M. (2003). Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763-770.
25. Hu, J., Yu, X., Wang, Z., Wang, F., Wang, L., Gao, H., Chen, Y., Zhao, W., Jia, Z., Yan, S. et al. (2013). Long term effects of the implantation of Wharton's jellyderived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr. J. 60, 347-357.
26. Ito, T., Itakura, S., Todorov, I., Rawson, J., Asari, S., Shintaku, J., Nair, I., Ferreri, K., Kandeel, F. and Mullen, Y. (2010). Mesenchymal stem cell and islet cotransplantation promotes graft revascularization and function. Transplantation 89, 1438-1445.
27. Kong, D., Zhuang, X., Wang, D., Qu, H., Jiang, Y., Li, X., Wu, W., Xiao, J., Liu, X., Liu, J. et al. (2014). Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin. Lab. 60, 1969-1976.
28. Kono, T. M., Sims, E. K., Moss, D. R., Yamamoto, W., Ahn, G., Diamond, J., Tong, X., Day, K. H., Territo, P. R., Hanenberg, H. et al. (2014). Human adiposederived stromal/stem cells protect against STZ-induced hyperglycemia: Analysis of hASC-derived paracrine effectors. Stem Cells 32, 1831-1842.
29. Lechner, A., Yang, Y.-G., Blacken, R. A., Wang, L., Nolan, A. L. and Habener, J. F. (2004). No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53, 616-623.
30. Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D. and Prockop, D. J. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 103, 17438-17443.
31. Leiter, E. H. (1982). Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc. Natl. Acad. Sci. USA 79, 630-634.
32. Lenzen, S. (2008). The mechanisms of alloxan- And streptozotocin-induced diabetes. Diabetologia 51, 216-226.
33. Livak, K. J. and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
34. Lopez, Y., Lutjemeier, B., Seshareddy, K., Trevino, E. M., Hageman, K. S., Musch, T. I., Borgarelli, M. and Weiss, M. L. (2013). Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: A preliminary report. Curr. Stem Cell Res. Ther. 8, 46-59.
35. McGuirk, J. P. and Weiss, M. L. (2011). Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review). Placenta 32 Suppl. 4, S304-S310.
36. Nakamura, T., Sakai, K., Nakamura, T. and Matsumoto, K. (2011). Hepatocyte growth factor twenty years on: much more than a growth factor. J. Gastroenterol. Hepatol. 26 Suppl. 1, 188-202.
37. Nauta, A. J. and Fibbe, W. E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499-3506.